Claudio Bertuccioli, Phd Email & Phone Number

Remote

VP Medical Strategy GSW Advertising & GENICOS-- Medical strategy lead for key oncology accounts at GSW Columbus-- Medical strategy lead for GENICOS, focused on breakthrough oncology and precision medicine-- Member of brand leadership team for Astellas' Vyloy launch in gastric cancer-- Member of brand leadership team for SOBI's VONJO, for myelofibrosis-- Medical oversight for LOXO@Lilly oncology-- Medical oversight for 3 senior medical writers-- Lead medical strategist on several new oncology client pitches

Head of Scientific Strategy for Rad Science, a scientific visualization/animation/experiential design studio.- Responsible for overseeing scientific strategy across main corporate (both medcoms and commercial) accounts, including managing a small team of writers/editors and interfacing with Account, Project Managment and Production teams- Wrote narrative scripts and storyboards for dozens of 2D and 3D MoD/MoA animations, illustrations, compound cards, conference installations, brochures and websites for Novartis Oncology, BMS Oncology, Eisai Neurosciences and other clients- Developed/oversaw referencing and annotations to support scientific claims being made- Provided iterative scientific oversight for production and account teams- As part of a client-facing team, I oversaw the scientific integrity of materials produced for clients and ensured that all clients had confidence in the agency's proactive scientific communications- Therapeutic areas of focus: Oncology, Hematology, Neurology, Fibrosis

New York, Ny, Us

- Developed competitive landscape decks for lung cancer and head and neck cancer, covering standards of care, all key data for successive lines of therapy and a comparison of key recent competitive clinical trials data- Developed manuscripts and decks serving as backgrounders for training on various safety topics in rheumatoid arthritis, relating key adverse events to filgotinib's mechanism of action and explaining possible safety benefits

Principal content strategist for the US team at AS&K Communications, Inc., a London-based medical marketing and communications agency. • Led overall content strategy and research for the US team, managing an editorial team in London consisting of 3 writers and overseeing content production with AS&K’s creative department.• Worked closely with AS&K management team to build and manage key strategic accounts both in pharma and medical devices.• Played senior roles in projects on both the medical marketing and medical communications sides of AS&K’s business (AS&K/Remedica).

Senior writer/strategist on both the marketing (AS&K) and medical affairs (Remedica) teams at AS&K, a London-based global medical marketing and communications agency focused on pharmaceuticals and medical devices.

Calder Biosciences has developed a proprietary protein stabilization technology based on the introduction of targeted dityrosine bonds, which lock the protein into a desired conformation.Using its dityrosine technology conformational locking technology, Avatar has generated candidate vaccines against RSV, influenza (universal) and HIV, that are now being tested in animals

Oxford Lotus Fund is a new impact investment fund currently in incubation, whose goal is to invest in low-cost medical technologies (primarily medical devices and diagnostics) and related healthcare services targeting the needs of the 'emerging middle class' in India.Led fund formation, team building and fundraising activities. Secured ~$500K seed funding from Oxford University, The George Institute and private investors. Recruited experienced investment team in India and US.

Early-stage lifesciences VC, investing in medical device and biotech company formationFounder of ABV's West Coast office

New York, Ny, Us

Venture Capital investments in pharmaceuticals and biotech startups.~ $200MM invested into 20 startups with 5 IPOs and 4 exits to date

Cambridge, Ma, Us

Venture Capital investments in early-stage internet and biotech startups

Internet angel investment fund

Worked closely with CEO to get this biotech (protein engineering) startup off the ground

Strategic Management Consulting based on risk modeling for global financial institutions.

Extension of thesis research and publication of peer-reviewed scientific papers.

Phd, Molecular Genetics & Developmental Biology

Ma, Molecular Biology & Genetics